LPCAT1 is implicated in various cancer types; overexpression of LPCAT1 was recently described in colorectal cancer, prostate cancer, lung cancer, and clear cell renal cell carcinomas [13–16]. This evidence concerns the gene LPCAT1 and prostate cancer.